Always review the manufacturers stability recommendations
WFI (Water for Injection) Approved for human use Manufactured in the United Arab Emirates by a DHA-licensed compounding pharmacy Optimized pH , suitable for a wide range of peptides, including sensitive compounds such as Tesamorelin Contains 0.9% benzyl alcohol USP as a bacteriostatic preservative Quality tested for endotoxins, sterility, pH, benzyl alcohol content, and heavy metals Common uses: Reconstitution of lyophilized compounds and multi-dose vial preparation Format: Sterile injectable solution Specifications: Sterile solution | Storage: 2-8C Use only as directed by a qualified healthcare professional
Trial dose range: 112mg, once weekly, subcutaneous Standard escalation: 2mg +2mg every 4 weeks 12mg (~20 weeks) Pharmacokinetics: half-life ~6 days
As it was mentioned above, benzyl alcohol negatively affects newborns, but there is lack of research on how it could be potentially toxic in pediatric patients ( For Lab Use Only This information is for educational purposes and does not qualify as medical advice
Every batch is HPLC-verified at 99% purity with a batch-specific Certificate of Analysis, published on our COA page
Being willing to adjust the schedule based on clinical need, rather than administrative convenience